Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Statistics

Total Valuation

APRE has a market cap or net worth of $7.51 million. The enterprise value is -$6.18 million.

Market Cap	7.51M
Enterprise Value	-6.18M

Important Dates

The last earnings date was Wednesday, November 12, 2025, before market open.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

APRE has 6.31 million shares outstanding. The number of shares has increased by 23.17% in one year.

Current Share Class	6.31M
Shares Outstanding	6.31M
Shares Change (YoY)	+23.17%
Shares Change (QoQ)	+4.76%
Owned by Insiders (%)	10.30%
Owned by Institutions (%)	17.11%
Float	5.12M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.88
Forward PS	n/a
PB Ratio	0.65
P/TBV Ratio	0.69
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.20

Current Ratio	5.20
Quick Ratio	5.12
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -74.72% and return on invested capital (ROIC) is -49.49%.

Return on Equity (ROE)	-74.72%
Return on Assets (ROA)	-41.90%
Return on Invested Capital (ROIC)	-49.49%
Return on Capital Employed (ROCE)	-118.70%
Revenue Per Employee	$61,030
Profits Per Employee	-$1.63M
Employee Count	8
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.04% in the last 52 weeks. The beta is 1.56, so APRE's price volatility has been higher than the market average.

Beta (5Y)	1.56
52-Week Price Change	-64.04%
50-Day Moving Average	1.43
200-Day Moving Average	1.84
Relative Strength Index (RSI)	34.57
Average Volume (20 Days)	104,556

Short Selling Information

The latest short interest is 69,543, so 1.10% of the outstanding shares have been sold short.

Short Interest	69,543
Short Previous Month	49,837
Short % of Shares Out	1.10%
Short % of Float	1.36%
Short Ratio (days to cover)	0.55

Income Statement

In the last 12 months, APRE had revenue of $488,239 and -$13.04 million in losses. Loss per share was -$2.14.

Revenue	488,239
Gross Profit	-7.91M
Operating Income	-13.82M
Pretax Income	-13.04M
Net Income	-13.04M
EBITDA	-13.80M
EBIT	-13.82M
Loss Per Share	-$2.14

Balance Sheet

The company has $13.72 million in cash and n/a in debt, giving a net cash position of $13.72 million or $2.17 per share.

Cash & Cash Equivalents	13.72M
Total Debt	n/a
Net Cash	13.72M
Net Cash Per Share	$2.17
Equity (Book Value)	11.64M
Book Value Per Share	1.83
Working Capital	11.26M

Cash Flow

Operating Cash Flow	-13.44M
Capital Expenditures	n/a
Free Cash Flow	-13.44M
FCF Per Share	-$2.13

Margins

Gross Margin	n/a
Operating Margin	-2,829.92%
Pretax Margin	-2,670.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.17%
Shareholder Yield	-23.17%
Earnings Yield	-173.07%
FCF Yield	-178.45%

Analyst Forecast

The average price target for APRE is $20.00, which is 1,580.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	1,580.67%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	139.71%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Feb 13, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

APRE has an Altman Z-Score of -31.57. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-31.57
Piotroski F-Score	n/a